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Introduction
Mental disorders have a high prevalence of up to 20 % in
children and adolescents worldwide and are often associ-
ated with substantial psychosocial impairments [1]. Many
mental disorders with an early onset in childhood or ado-
lescence have a high likelihood of persistence or recurrence
of symptoms and are risk factors for other psychiatric
disorders in adulthood [2]. Against this background, sig-
nificant attention has been paid to the development of
psychological therapies for children and adolescents that
aim to reduce current symptom levels and their detrimental
effects on functioning and developmental trajectories.
The earliest reviews of these psychological therapies
included studies with mostly low methodological quality.
They found that the rate of improvement did not differ
significantly whether or not any type of psychotherapy was
provided. The authors [3, 4] emphasized the need for more
stringent standards in intervention research and more
specified, well-documented treatments. This led to an
increase in randomized controlled trials (RCTs) which
demonstrated that psychotherapy can indeed produce sig-
nificant benefit compared to control conditions (e.g. [5–7]).
These results have coalesced into evidence-based treat-
ments for children and adolescents applicable to several
diagnostic categories including anxiety disorders, depres-
sive disorders, eating disorders, autism spectrum disorders,
substance abuse, and attention deficit hyperactivity disor-
ders [8, 9]. The majority of these treatments under study in
this age group can be described by the umbrella term
‘cognitive-behavioural therapy’ (CBT); they include both
programmes designed specifically for children and ado-
lescents and generic approaches for all age groups such as
CBT for anxiety disorders [8, 10]. With the number of
evidence-based treatments expanding, research has started
to draw on the relative efficacy of treatments for specific
subtypes of disorders [10] and different intervention tech-
niques for the same disorder [11]. For example, the review
by Leenarts et al. [11] in this issue reported that trauma-
focused CBT techniques revealed better empirical support
for the treatment of children exposed to maltreatment than
both non-trauma focused methods and trauma-specific
treatments for children and adolescents with comorbid
disorders. Recent studies also investigated combined
effects of psychopharmacologic and psychotherapeutic
interventions but found no consistent evidence favouring
integrated interventions (e.g. [12]). In summary, child and
adolescent psychotherapy research has shown remarkable
progress towards evidence-informed treatments in recent
years. However, it seems important to move on to sur-
mount methodological and conceptual limitations.
Methodological aspects
Despite the increase in the quantity of evaluation studies,
child and adolescent psychiatry is still far from having a
knowledgebase sufficient for creating evidence-informed
decisions about psychotherapy for all mental disorders.
This is at least partially due to the low methodological
quality of the majority of these studies. Therefore, the
conclusions of recent meta-analyses and reviews of treat-
ment efficacy for given disorders were often preliminary or
inconclusive, because the number of included RCTs was
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generally small, often with low statistical power and a high
or even unknown risk for biased sample selection and
randomization procedures [10, 13, 14]. In addition, most of
these studies suffered from selective outcome reporting,
and about one-third of the published studies included a
follow-up assessment with a mean time-lag of 5 months
after therapy only [8, 14]. Therefore, the durability of
treatment effects remains largely unclear. As a conse-
quence, we do not know yet whether treatment gains could
be maintained by additional treatments or booster-sessions.
This underlines the need for larger, methodologically
sound RCTs assessing long-term effects. In addition, cost-
benefit analyses may highlight psychotherapy’s potential to
reduce the direct and indirect costs associated with child
and youth mental health problems by alleviating psycho-
social impairments.
Current assessments of therapeutic change are often
limited to symptom domains and are mostly administered
in a highly standardized setting in the laboratory. Treat-
ment effects, however, should also generalize to different
facets of the problem (e.g. cognitive, emotional, social,
behavioural aspects) and to different contexts in everyday-
life [15]. Therefore, one measure or informant is not able to
capture all of these aspects of treatment efficacy. Another
limitation of current outcome assessment in child and
adolescent psychotherapy research is the reliance on few
and often non-blinded informants with low inter-informant
agreement across settings, for example, teachers and par-
ents [14, 16, 17]. This may lead to biased or inconsistent
information about treatment effects. A key issue in the
assessment of treatment effects is whether improvements
found in standardized, nomothetic measures that place the
individual’s functioning in a normative context are also
clinically relevant for the individual patient. Idiographic
assessments that take the individual patterns of change and
the individual developmental state into account are largely
ignored in the current literature [18].
Therefore, multiple measures and multiple informants are
needed to evaluate different aspects of the problem. More-
over, symptom and diagnostic measures should be supple-
mented by measures of real world-functioning across
various contexts like direct observation of the patient’s
behaviour (e.g. behaviour in school, at home, with friends).
The event sampling method (ESM) [19] may be a promising
measure of real world-functioning, because it allows
researchers to study individual experiences that vary across
time in their natural environment. As ESM minimizes recall
biases by the event-contingent assessment, it may also be
adequate for children with low levels of cognitive func-
tioning, who are otherwise often excluded from studies.
Newly developed person-focused assessments [20] address
the shortcomings of standardized, nomothetic measures.
They seem to be an efficient strategy for identifying intra-
individual changes in personally relevant treatment goals by
repeatedly assessing the problems that patients and their
care-givers consider to be most important.
The application of several measures and informants,
however, raises the question of how to deal with incon-
sistent findings. For example, what if some measures
support treatment efficacy but others do not? This question
has not been adequately addressed, because many
researchers tried to circumvent discussing inconsistent
findings by focussing only on significant outcomes or by
using terms such as ‘probably effective’ or ‘almost evi-
dence-based’ [21]. It seems important to develop clear
standards on how to integrate conflicting results based on
multiple outcome domains and outcome measures and how
to interpret them in terms of treatment efficacy.
The range of possible changes (RPC) model [22] may be
a helpful framework to this end, as it has been designed to
identify and integrate within- and between-study consis-
tencies in a systematic way. Future studies are needed to
assess the reliability and validity of RPC’s proposed clas-
sification scheme and the relevance of its clinical
implications.
Meta-analyses and reviews indicate that many kinds of
psychotherapy produce therapeutic effects in children and
adolescents (9, 34). However, more in depth-analyses of
treatment effects are necessary to identify under what
conditions these treatments work best (i.e. moderators; e.g.
gender, therapy setting and age) and to investigate how
they lead to change (i.e. mediators; e.g. therapeutic alliance
and self-efficacy expectations) [24, 25]. For example, few
treatments have been adapted to the special needs of pre-
school children [10]. Assessing the moderating effect of
age may have important implications towards a differential
indication of these interventions and may emphasize the
need to tailor therapies to the developmental stage of
participants. Mediation analysis may shed light on change
mechanisms on a cognitive [26], behavioural [25], and a
neuronal level [27] as well as their interactions. Mediation
analysis may also be an appropriate statistical method to
test critical components of multimodal treatments. Identi-
fying possible mechanisms of change would have impor-
tant clinical implications. Therapists could optimize effects
of current treatments by focusing on change mechanisms
that need to be targeted [28].
Conceptual aspects
Only a few manuals have been specifically developed for
children or adolescents. Many CBT treatments for children
and adolescents can be viewed as downward extensions of
intervention programmes originally designed for adult
patients [29]. This was done based on the assumption that
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the underlying theoretical models are directly generalizable
to younger age groups, but this has rarely been formally
tested. This assumption implies that patients with the same
diagnosis would all benefit from the same intervention
across the lifespan. However, this is not congruent with
empirical evidence reporting, e.g. smaller effect sizes for
children than for adolescents [30].
This highlights the need for studies to test the validity of
the underlying models and mechanisms of change across
different age groups. For example, it is important to gain a
precise understanding of the cognitive, emotional and
interpersonal prerequisites of the numerous intervention
techniques used in child and adolescent psychotherapy.
This may help in choosing the techniques most appropriate
to the current developmental state of an individual rather
than age per se.
A range of evidence-based treatments have been
developed in the past, however, they were only rarely
incorporated into clinical practice [31], and their efficacy
was substantially reduced when they were tested under
clinically representative general care conditions [23].
Possible implementation barriers accounting for these dif-
ferences may be that patients in service settings have
higher rates of comorbidities and more psychosocial
impairments as well as motivational problems. It is also
possible that different mechanisms leading to a respective
mental disorder are present in routine clinical care than in
research settings, thus rendering deviations from treatment
protocols mandatory [23]. These differences raise concerns
that treatments tested in RCTs may not be applicable to
patients treated in routine clinical care [32], because the
adherence to a predefined sequence of sessions with pre-
determined therapy contents in RCTs may constrain the
therapist’s ability to adapt each therapy session to the
individual treatment needs of a patient.
To address these concerns, modular [33] or stepped-care
models may be promising approaches. As more individu-
alized approaches they may facilitate the coverage of
comorbid problems and sequential changes in treatment
response without a substantial loss of internal validity.
Evaluation of such treatment concepts in child and ado-
lescent psychiatry is recommended to bridge the gap
between efficacy and effectiveness.
Conclusions
In summary, psychotherapy research in children and ado-
lescents has generated several evidence-based interventions
in recent years. At this point, we know much about what
outcomes are produced by treatments but have little
understanding what drives these changes. The need for
individualization in assessment and therapy is not new but
still in its infancy. Furthermore, treatments should be
adapted to a patient’s developmental level to optimize
treatment efficacy. Novel assessment methods and trial
designs that take individual treatment needs and the context
of problems into account seem promising to personalize
evidence-based treatments and thereby facilitate their
implementation into clinical practice.
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